Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies

Despite consistent progress in prompt diagnosis and curative therapies in the last decade, lung cancer (LC) continues to threaten mankind, accounting for nearly twice the casualties compared to prostate, breast, and other cancers. Statistics associate ~25% of 2021 cancer-related deaths with LC, more...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Parth, Rani, Ruma, Solanki, Raghu, Patel, Vishal Haribhai, Mukherjee, Tapan Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645466/
https://www.ncbi.nlm.nih.gov/pubmed/37970206
http://dx.doi.org/10.37349/etat.2023.00171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645466/
https://www.ncbi.nlm.nih.gov/pubmed/37970206
http://dx.doi.org/10.37349/etat.2023.00171

Ejemplares similares